E Pop
Overview
Explore the profile of E Pop including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
84
Citations
121
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pop E, Popa I, Bolcas D, Sirca D, Simon F, Costin V, et al.
Rev Med Chir Soc Med Nat Iasi
. 2014 Dec;
85(4):581-9.
PMID: 25528799
Cholesterolemia in a population of 100482 inhabitants of the Bihor district, subjected to screening for the risk factors in ischemic cardiopathy were studied. Together with hyperlipidemias other risk factors were...
2.
Kumar B, Min K, Bashirzadeh M, Farimani A, Bae M, Estrada D, et al.
Nano Lett
. 2013 Apr;
13(5):1962-8.
PMID: 23586702
A fundamental understanding of chemical sensing mechanisms in graphene-based chemical field-effect transistors (chemFETs) is essential for the development of next generation chemical sensors. Here we explore the hidden sensing modalities...
3.
Oniciu D, Pop E, Dasseux J, Mueller R, Yang I, Bell R, et al.
Pharmazie
. 2006 Mar;
61(2):157-65.
PMID: 16526566
Long hydrocarbon chain derivatives with bis-terminal hydroxyl or carboxyl groups and various central moieties (ketone, ether, ester, amide, carbamate, etc.) have been synthesized and evaluated for their effects on the...
4.
5.
Pop E, Buchwald P
SAR QSAR Environ Res
. 2001 Nov;
12(1-2):113-27.
PMID: 11697051
Dexanabinol and other synthetic 6aS-trans cannabinoids are devoid of cannabimimetic activity, as they do not have affinity toward cannabinoid receptors. On the other hand, these compound bind to the NMDA...
6.
Pop E
Curr Opin Investig Drugs
. 2001 Mar;
1(4):494-503.
PMID: 11249704
Dexanabinol is a non-psychotropic cannabinoid NMDA receptor antagonist under development by Pharmos Corp for the potential treatment of cerebral ischemia, glaucoma, Alzheimer's disease, cardiac failure, head injury and multiple sclerosis...
7.
Pop E
Curr Pharm Des
. 2000 Jul;
6(13):1347-60.
PMID: 10903397
Unlike natural cannabinoids which belong to the 6aR - trans series, the synthetic dexanabinol (HU-211), a 6aS-trans enantiomer, does not have affinity toward cannabinoid receptors and is devoid of cannabimimetic...
8.
Pop E
Pharmazie
. 2000 Apr;
55(3):167-71.
PMID: 10756534
Design, synthesis and study of water-soluble esters of dexanabinol are described. The solubility, stability and in vitro activity of various polar or permanently charged derivatives resulting by acylation of the...
9.
Pop E, Rachwal S, Vlasak J, Biegon A, Zharikova A, Prokai L
J Pharm Sci
. 1999 Nov;
88(11):1156-60.
PMID: 10564064
Trialkylammonium acetoxymethyl esters of dexanabinol were synthesized and evaluated as water-soluble prodrugs. Syntheses were performed by conventional methods; solubility in water and stability in buffers and human plasma were determined...
10.
Pop E
Curr Opin Chem Biol
. 1999 Jul;
3(4):418-25.
PMID: 10419842
The investigation of natural and synthetic cannabinoid ligands, including (-)-Delta(9)-tetrahydrocannabinol, cannabinol, cannabidiol, HU-210, HU-211, CT3, CP 55, 940, WIN 55, 212-2, SR 14, 1716A, anandamide, 2-arachidonoylglycerol, and numerous novel analogs,...